105 related articles for article (PubMed ID: 1204255)
1. Cytotoxicity of lymphocytes from healthy subjects and from melanoma patients against cultured melanoma cells.
Pavie-Fischer J; Kourilsky FM; Picard F; Banzet P; Puissant A
Clin Exp Immunol; 1975 Sep; 21(3):430-41. PubMed ID: 1204255
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons.
Peter HH; Knoop F; Kalden JR
Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):263-81. PubMed ID: 134545
[TBL] [Abstract][Full Text] [Related]
3. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
[TBL] [Abstract][Full Text] [Related]
4. Variables and specificity of in vitro lymphocyte-mediated cytotoxicity in human melanoma.
Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
Cancer Res; 1975 Dec; 35(12):3721-30. PubMed ID: 1192430
[TBL] [Abstract][Full Text] [Related]
5. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous cytotoxicity (SCMC) of normal human lymphocytes against a human melanoma cell line: a phenomenon due to a lymphotoxin-like mediator.
Peter HH; Eife RF; Kalden JR
J Immunol; 1976 Feb; 116(2):342-8. PubMed ID: 1082453
[TBL] [Abstract][Full Text] [Related]
8. Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity.
Fidler IJ; Gersten DM; Budmen MB
Cancer Res; 1976 Sep; 36(9 pt.1):3160-5. PubMed ID: 975082
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.
Itoh K; Tilden AB; Balch CM
Cancer Res; 1986 Jun; 46(6):3011-7. PubMed ID: 3486040
[TBL] [Abstract][Full Text] [Related]
10. Human malignant melanoma cells: morphological and immunological variations.
Hakim AA
Neoplasma; 1977; 24(1):81-99. PubMed ID: 840339
[TBL] [Abstract][Full Text] [Related]
11. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements.
Gervois N; Heuze F; Diez E; Jotereau F
Eur J Immunol; 1990 Apr; 20(4):825-31. PubMed ID: 1971794
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.
Mukherji B; Wilhelm SA; Guha A; Ergin MT
J Immunol; 1986 Mar; 136(5):1888-92. PubMed ID: 2419418
[TBL] [Abstract][Full Text] [Related]
13. [Cytotoxic immunity indices of melanoma B16 growth in mice].
Korosteleva TA; Veresova OV
Vopr Onkol; 1980; 26(1):67-70. PubMed ID: 7355591
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.
Mukherji B; Nashed AL; Guha A; Ergin MT
J Immunol; 1986 Mar; 136(5):1893-8. PubMed ID: 2419419
[TBL] [Abstract][Full Text] [Related]
15. [Cytotoxicity of the lymphocytes of melanoma patients against autologous tumor cells and its in vitro enhancement].
Bykovskaia SN; Iobadze MS; Kupriianova TA; Demidov LV
Biull Eksp Biol Med; 1987 Jan; 103(1):86-9. PubMed ID: 2948576
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a chimpanzee anti-human melanoma antiserum.
Stuhlmiller GM; Seigler HF
Cancer Res; 1975 Aug; 35(8):2132-7. PubMed ID: 1149027
[TBL] [Abstract][Full Text] [Related]
17. Induction of cytotoxic T lymphocytes from the peripheral blood of a hepatocellular carcinoma patient using melanoma antigen-1 (MAGE-1) peptide.
Lu J; Leng X; Peng J; Mou D; Pang X; Shang X; Chen W
Chin Med J (Engl); 2002 Jul; 115(7):1002-5. PubMed ID: 12150730
[TBL] [Abstract][Full Text] [Related]
18. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
[TBL] [Abstract][Full Text] [Related]
19. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
[TBL] [Abstract][Full Text] [Related]
20. [Cytotoxic index in melanoma patients].
Sviatukhin MV; Razmakhnina NG; Lysenkova EM
Vopr Onkol; 1977; 23(11):14-8. PubMed ID: 595509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]